Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Howe who wrote (1302)	10/14/1998 3:15:00 PM
From: M. Ramle	Read Replies (1) of 10280

David: I share your concerns regarding the possibility of any litigation if Lilly so chooses, but let's us not forget that the main threat to Lilly is not all contained in the SEPR camp but rather in the generic-drug Manufacturers who are strongly gearing up to bring their own anti-depressant products to market when Lilly's Prozac patent expires. In addition, other major Pharmaceutical companies (such as Merck, Glaxo-Wellcome, etc.) are literally racing to bring their new anti-depressant drugs to market as well. Therefore, having to choose between all evils in this situation, I personally believe that Lilly is best off siding with SEPR in a joint-venture agreement. SEPR is actually playing their game with a very impressive and straight POKER face. GOOD LUCK. Mazen

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next